Fundz

Harness Therapeutics Secures Additional £4 Million Funding To Pursue Physiological Upregulation Approach To Treat Neurodegenerative Diseases

PRIVATENov 28, 2023

Amount Raised

£4 Million

Round Type

Funding Round

CambridgeBiotechnologyHealth CareTherapeutics

Description

Harness Therapeutics (‘Harness’, previously Transine Therapeutics), a biotechnology company focused on physiological protein upregulation to develop next generation therapeutics for the treatment of neurodegenerative diseases, announces that it has successfully raised an additional £4 million in funding from its existing investors, bringing the total invested to £17.6 million. Proceeds will be used to advance Harness’ lead Huntington’s Disease (HD) programme targeting FAN1 nuclease and pursue target discovery and validation activities in other neurodegenerative disease pathways

Quick answer

Harness Therapeutics raised £4 Million in a Funding Round round, dated November 28, 2023. Harness Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Harness Therapeutics raise?
Harness Therapeutics raised £4 Million in a Funding Round round on November 28, 2023.
What does Harness Therapeutics do?
From this work, the company has gained unique insights into the regulation of therapeutic targets and broadened its oligonucleotide based toolset for physiological protein upregulation. *** About Harness Therapeutics..
Where is Harness Therapeutics based and how big is it?
Harness Therapeutics is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Harness Therapeutics?
Fundz holds 1 contact at Harness Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Harness Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Gallant raised $15M (Series A) on January 8, 2024.
  • Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
  • Liquidia raised $100M (Funding Round) on January 4, 2024.
  • OnCusp Therapeutics raised $100M (Series A) on January 4, 2024.
  • Voyager Therapeutics raised $20M on January 3, 2024.
  • Alpha Cognition raised $1.8M (Seed) on December 22, 2023.

Who to call at Harness Therapeutics, and when

A new round usually means Harness Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Harness Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Harness Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Harness Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Harness Therapeutics

Location

Cambridge, Massachusetts, United States

About

From this work, the company has gained unique insights into the regulation of therapeutic targets and broadened its oligonucleotide based toolset for physiological protein upregulation. *** About Harness Therapeutics Harness Therapeutics is a biotechnology company focused on the development of next generation therapeutics for the treatment of neurodegenerative diseases, with a lead programme in Huntington’s Disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Harness Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Harness Therapeutics's next move

See what Strategic adds

Harness Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.